-
Are You Ready to Lead in Diabetes Care and Education?
As I returned from Chicago after the Association of Diabetes Care & Education Specialists Board of Directors orientation and quarterly meeting, I found myself reflecting on what it means to lead in a field that is evolving faster than ever. With rapid advances in technology, changes in telehealth opportunities, and the emergence of new therapies like GLP-1s for obesity treatment, it is clear that the future of diabetes care will be shaped not only by seasoned experts but also by those willing to step forward, ask questions, and share fresh ideas. Walking into that room as an incoming board member…
-
The State of Wellness: Glucose Tracking Is Having a Moment
If you’re not already using continuous glucose monitoring (CGM) in your practice, it’s time to start. Catch up or risk getting left behind, because glucose tracking for metabolic health is having a moment. From diabetes prevention to metabolic optimization and athletic performance, CGM is everywhere. And it’s easier than ever to get started. With just a few clicks, direct-to-consumer CGMs like Abbott’s Lingo and Dexcom’s Stelo can be delivered straight to your doorstep, sometimes in less than 24 hours. I know, because I’ve tried them myself! Earlier this year, Abbott released a white paper on the state of wellness, exploring…
-
Nutrition and Type 1 Diabetes: Supporting Safe and Sustainable Weight Loss
I recently had the opportunity to contribute to an upcoming text from the American Diabetes Association on nutrition therapy in diabetes care. Specifically, I was tasked with reviewing and rewriting a chapter on nutrition recommendations for adults with type 1 diabetes and insulin-requiring type 2. In my excitement for its upcoming publication, I wanted to share a preview of what makes weight and fat loss in type 1 diabetes uniquely complex and highlight evidence-based strategies for supporting safe, sustainable weight management in this population. I hope this sneak peek sparks curiosity and encourages you to consider adding this valuable resource…
-
Nutrition and Type 1 Diabetes: What Are Best Practices for Insulin Dosing?
I recently had the opportunity to contribute to an upcoming text from the American Diabetes Association on nutrition therapy in diabetes care. Specifically, I was tasked with reviewing and rewriting a chapter on nutrition recommendations for adults with type 1 diabetes and insulin-requiring type 2. In my excitement for its upcoming publication, I want to share a preview of some best practices for insulin dosing for individuals on multiple daily injections (MDI). What are the strategies for dosing insulin with meals? How can doses be adjusted? And how do factors like exercise, alcohol, or stress come into play? I hope…
-
Nutrition and Type 1 Diabetes: What about Protein and Fat?
I recently had the opportunity to contribute to an upcoming text from the American Diabetes Association on nutrition therapy in diabetes care. Specifically, I was tasked with reviewing and rewriting a chapter on nutrition recommendations for adults with type 1 diabetes and insulin-requiring type 2. In my excitement for its upcoming publication, I want to share a preview of my key findings on the role of fat and protein. Does fat and protein impact glycemic? What is the ideal amount? Does it require additional insulin? I hope this sneak peek sparks curiosity and encourages you to consider adding this valuable resource…
-
Nutrition and Type 1 Diabetes: Do Carbohydrates Matter?
I recently had the opportunity to contribute to an upcoming text from the American Diabetes Association on nutrition therapy in diabetes care. Specifically, I was tasked with reviewing and rewriting a chapter on nutrition recommendations for adults with type 1 diabetes and insulin-requiring type 2. In my excitement for its upcoming publication, I’d like to share a preview of some key findings on carbohydrates. Is carbohydrate counting still relevant today? Does the type of carbohydrate make a difference? And how do approaches like low-carb or keto eating fit in? My hope is that this sneak peek sparks curiosity and inspires…
-
Nutrition and Type 1 Diabetes: A Four-Part Series
I recently had the opportunity to contribute to an upcoming text from the American Diabetes Association on medical nutrition therapy for the management of diabetes. Specifically, I was tasked with reviewing and substantially rewriting a chapter focused on nutrition therapy recommendations for adults with type 1 diabetes and insulin-requiring type 2 diabetes. This was by far one of the most challenging and rewarding projects I’ve taken on, rivaling even my graduate thesis (which included over 110 citations!). The chapter is deeply researched and reflects countless hours of work, reflection, and revision, though at this point, it all feels like a…
-
ADCES25: Thriving in Diabetes Care & Education
The last week was a whirlwind of learning, growing, connecting, and plenty of laughs. Because when a bunch of diabetes care and education specialists get together, you know you’ve found your people. Who else gets excited to talk about CGM reports, autoantibody labs, and even bowel movements at 10 PM on a Saturday night? (Definitely a good call to leave the family at home for this one!) Every year when I head to the Association of Diabetes Care & Education Specialists Annual Conference, I’m reminded how powerful it is to have a strong professional network, especially when you’re running your…
-
How Virtual Dietitians Are Expanding Access to Diabetes Care
For years, nutrition support has been an essential but underutilized part of diabetes care. Despite strong evidence that medical nutrition therapy improves outcomes, many people with diabetes have faced challenges accessing consistent, high-quality guidance from registered dietitians. That’s beginning to change. Virtual care is breaking down long-standing barriers, making it easier to connect with dietitians in timely, flexible, and personalized ways. As a result, virtual dietitians are helping close critical gaps in care, and nutrition counseling is becoming more central and more accessible than ever before.
-
Debunk the Junk: 4 Common Myths About Insulin Pumps
Starting on an insulin pump can feel like a big step, especially for someone who’s been managing their diabetes a certain way for years. But with the right support, it can also be an empowering transition. As clinicians, we each bring our own experiences and perspectives when it comes to diabetes technology. And often, our patients surprise us in wonderful ways. That’s why it’s helpful to pause and reflect on the assumptions we may carry about who’s “right” for pump therapy. Let’s explore a few common myths I hear in practice. By unpacking these together, we can make more personalized,…
-
Obesity Care vs. Weight Loss: What’s the Difference?
The International Obesity Collaborative, a global alliance of professional organizations focused on improving obesity care, recently released a powerful consensus statement: obesity care and weight loss are not the same. You might be wondering: What’s the difference? Isn’t all obesity care centered around weight loss? And wouldn’t weight loss be appropriate for someone with obesity? The answer may surprise you. Let’s take a closer look at the International Obesity Collaborative’s new consensus statement, what it means for healthcare professionals, and how it could reshape the way we approach obesity treatment in clinical practice.
-
Goodbye BMI? Why Body Composition Is Gaining Ground in Clinics
The rise of incretin-based therapies for obesity care, like Wegovy (semaglutide) and Zepbound (tirzepatide), has brought renewed attention to the risk of muscle atrophy that can accompany rapid weight loss. To better assess changes in skeletal muscle mass, clinicians are turning to body composition assessment tools to track progress over time. However, the ability to measure, interpret, and communicate changes in body composition is a skill most clinicians haven’t been formally trained in, leaving many feeling like it’s not a tool they can confidently use. I want to push back against that assumption and offer some basic principles to help…
-
DCES Leadership in the Future of Wearable Health Technology
In a recent issue of Healthcare150, a newsletter spotlighting key healthcare trends, I was struck by the projected growth of wearable devices—from $14.5 billion in 2020 to $76.1 billion by 2029. In my nutrition practice, I see just how common sleep, activity, and glucose trackers have become. This kind of growth points to a broader shift, that digital health tools are becoming deeply integrated into mainstream self care. Wearables are now central to both cost-efficiency efforts in healthcare and the growing demand for a highly personalized approach. Here are a few standout trends—and the exciting opportunities I see for diabetes…
-
GLP-1 Therapy Part 4: Navigating the Decision to Discontinue
I recently had the pleasure of speaking at the Colorado Academy of Nutrition and Dietetics Annual Conference on the topic of nutrition strategies for effective GLP-1 use in obesity treatment. This premier event, dedicated to supporting nutrition and dietetics professionals in Colorado, offered a valuable opportunity to share updated evidence on GLP-1 therapies, while also debunking common myths to promote informed and unbiased nutrition counseling. In this four-part series, I’m excited to share my key recommendations to help support your practice. In Part 4, we’ll discuss some of the key questions to consider when deciding whether to discontinue therapy. New…
-
GLP-1 Therapy Part 3: Strategies for Successful Weight Loss
I recently had the pleasure of speaking at the Colorado Academy of Nutrition and Dietetics Annual Conference on the topic of nutrition strategies for effective GLP-1 use in obesity treatment. This premier event, dedicated to supporting nutrition and dietetics professionals in Colorado, offered a valuable opportunity to share updated evidence on GLP-1 therapies, while also debunking common myths to promote informed and unbiased nutrition counseling. In this four-part series, I’m excited to share my key recommendations to help support your practice. In Part 3, we’ll discuss strategies for successful weight loss while on GLP-1 therapy, as well as the transition…
-
GLP-1 Therapy Part 2: Preventing and Managing Side Effects
I recently had the pleasure of presenting at the Colorado Academy of Nutrition and Dietetics Annual Conference on the topic of nutrition strategies for effective GLP-1 use in obesity treatment. This premier event, dedicated to supporting nutrition and dietetics professionals in Colorado, offered a valuable opportunity to share updated evidence on GLP-1 therapies, while also debunking common myths to promote informed and unbiased nutrition counseling. In this four-part series, I’m excited to share my key recommendations to help support your practice. In Part 2, we’ll discuss strategies for managing and preventing medication-related side effects New to this series? Start with…
-
GLP-1 Therapy Part 1: Setting Realistic Weight Loss Expectations
I recently had the pleasure of speaking at the Colorado Academy of Nutrition and Dietetics Annual Conference on the topic of nutrition strategies for effective GLP-1 use in obesity treatment. This premier event, dedicated to supporting nutrition and dietetics professionals in Colorado, offered a valuable opportunity to share updated evidence on GLP-1 therapies, while also debunking common myths to promote informed and unbiased nutrition counseling. In this four-part series, I’m excited to share my key recommendations to help support your practice. In Part 1, we’ll explore key considerations for identifying appropriate GLP-1 candidates and highlight the importance of setting realistic…
-
Double Diabetes: Supporting Patients Through the Diagnostic Overlap
If you’ve never heard the term “double diabetes” before, don’t be alarmed. It’s not an official diagnosis, and you likely won’t find it in a medical textbook. However, it’s a term that’s gaining traction to describe a growing population of adults whose diabetes doesn’t fit neatly into the diagnostic criteria for either type 1 or type 2. Sometimes referred to as “hybrid diabetes,” “type 1.5,” or “LADA” (Latent Autoimmune Diabetes in Adults), recent research suggests that the distinction between type 1 and type 2 diabetes is less clear-cut than previously thought. In some cases, features of both types can coexist.…
-
Blood Sugar Trends: Defining What’s Truly “Normal”
With the rise of direct-to-consumer continuous glucose monitoring, there has been growing interest in understanding blood sugar trends. Reasons for CGM use include to improve metabolic health, prevent diabetes, enhance sports performance and recovery, or simply out of curiosity. Users can access real-time data, averages, trends, and insights at any time, day or night. With all this data, you might find yourself wondering: What do my numbers mean? Should I be concerned? Is this normal? All valid questions. Let’s explore the evidence behind defining “normal” blood sugar trends. Diagnosing Diabetes To define what is considered normal, it’s best to start…
-
Fatty Liver on the Rise: What You Need to Know
A recent study published in the Journal of the American Medical Association estimates that over 40% of the U.S. population will develop metabolic dysfunction–associated steatotic liver disease (MASLD), commonly known as fatty liver, by 2050—equating to approximately 122 million adults. This number is both astounding and concerning, especially as fatty liver disease is rapidly becoming one of the leading causes of liver transplants—and a new liver isn’t easy to come by. In fact, the study predicts that liver cancer cases will double, while the need for liver transplants will quadruple. This raises an urgent question: What is being done to…